Literature DB >> 9088158

The dolastatins.

G R Pettit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9088158     DOI： 10.1007/978-3-7091-6551-5_1

Source DB:  PubMed          Journal:  Fortschr Chem Org Naturst        ISSN： 0071-7886


× No keyword cloud information.
  23 in total

Review 1.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

Review 2.  Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.

Authors:  Satish K Singh; Donna L Luisi; Roger H Pak
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

Review 3.  Enriching cancer pharmacology with drugs of marine origin.

Authors:  Paula C Jimenez; Diego V Wilke; Paola C Branco; Anelize Bauermeister; Paula Rezende-Teixeira; Susana P Gaudêncio; Leticia V Costa-Lotufo
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

4.  Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans.

Authors:  Tanja Woyke; Robert W Roberson; George R Pettit; Günther Winkelmann; Robin K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin.

Authors:  Zhao Hui Li; Qian Zhang; Hai Bin Wang; Ya Nan Zhang; Ding Ding; Li Qiang Pan; David Miao; Shi Xu; Chen Zhang; Pei Hua Luo; Hua Naranmandura; Shu Qing Chen
Journal:  Invest New Drugs       Date:  2013-08-01       Impact factor: 3.850

6.  Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.

Authors:  George R Pettit; Thomas H Smith; Jun-Ping Xu; Delbert L Herald; Erik J Flahive; Collin R Anderson; Paul E Belcher; John C Knight
Journal:  J Nat Prod       Date:  2011-05-03       Impact factor: 4.050

7.  Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.

Authors:  George R Pettit; Fiona Hogan; Steven Toms
Journal:  J Nat Prod       Date:  2011-05-02       Impact factor: 4.050

8.  The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity.

Authors:  Krishna Mohan Bajjuri; Yuan Liu; Cheng Liu; Subhash C Sinha
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

Review 9.  Impact of marine drugs on cytoskeleton-mediated reproductive events.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2010-03-25       Impact factor: 5.118

10.  Differential gene expression in auristatin PHE-treated Cryptococcus neoformans.

Authors:  Tanja Woyke; Michael E Berens; Dominique B Hoelzinger; George R Pettit; Günther Winkelmann; Robin K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.